These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9218159

  • 21. [Heparin-induced thrombocytopenia].
    Depasse F, Samama MM.
    Ann Biol Clin (Paris); 2000; 58(3):317-26. PubMed ID: 10846236
    [Abstract] [Full Text] [Related]

  • 22. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
    Gillis S, Merin G, Zahger D, Deeb M, Drenger B, Hyam E, Eldor A.
    Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
    [Abstract] [Full Text] [Related]

  • 23. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW, Eichler P, Glöckner WM, Ranze O, Greinacher A.
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Loss of extremities caused by heparin-induced thrombocytopenia].
    Wenzl ME, Leffringhausen W, Scherlitzky L.
    Unfallchirurg; 1996 Aug; 99(8):607-11. PubMed ID: 8975383
    [Abstract] [Full Text] [Related]

  • 27. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
    Herzog S, Rath W, Kuhn W.
    Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
    [Abstract] [Full Text] [Related]

  • 28. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
    Salmi L, Leroy-Matheron C, LeBesnerais P, Rosanval O, Duvaldestin P, Gouault-Heilmann M.
    Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
    Keeling DM, Richards EM, Baglin TP.
    Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Heparin-induced thrombocytopenia: what clinicians need to know.
    Chong BH, Isaacs A.
    Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
    Castelino RL, Maddula M, Tarafdar S, Sud K, Kairaitis L.
    Thromb Res; 2019 Aug; 180():70-73. PubMed ID: 31229923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.